Ethical Implications of the Fecal Microbiota Transplantation: Disclosure of a False-Positive HIV Test
Fecal microbiota transplantation (FMT) has gained popularity as an effective therapeutic option for Clostridioides difficile infection (CDI). Since its FDA recognition as a treatment modality for recurrent CDI in 2013, screening protocols for FMT donor stool have been in flux. However, extensive hea...
Saved in:
| Main Authors: | Caitlyn Hollingshead, Jacob Ciricillo, Joel Kammeyer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2021/6696542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canadian Association of Gastroenterology Position Statement: Fecal Microbiota Transplant Therapy
by: Paul Moayyedi, et al.
Published: (2014-01-01) -
Fecal microbiota transplantation: present and future
by: Ra Ri Cha, et al.
Published: (2025-05-01) -
Impact of fecal microbiota transplantation in dogs
by: Leon Cantas, et al.
Published: (2025-07-01) -
Fecal microbiota transplantation alters the proteomic landscape of inflammation in HIV: identifying bacterial drivers
by: Claudio Díaz-García, et al.
Published: (2024-10-01) -
Fecal Microbiota Transplantation: Past, Present and Future
by: N. V. Yevdokimova, et al.
Published: (2019-08-01)